2024-09-01 - Analysis Report
## CVS Stock Analysis Report

This report provides a comprehensive analysis of CVS Health Corporation (CVS), a leading healthcare company offering pharmacy, healthcare, and retail services.

**1. Performance & Comparison:**

CVS stock has underperformed the S&P 500 (VOO) significantly, with a cumulative return of -17.37% compared to 89.66% for the benchmark. This results in a substantial divergence of -107.03%, indicating that CVS has been lagging behind the market significantly.

**2. Recent Price Movement:**

The closing price of CVS is currently $57.24. The stock is slightly below its 5-day moving average ($57.52) and 20-day moving average ($57.56). However, it is trading below its 60-day moving average ($58.95), suggesting a potential downward trend.

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** At 59.78, the RSI indicates that CVS is currently in neutral territory, not showing strong signs of overbought or oversold conditions. 
* **PPO (Percentage Price Oscillator):** A negative PPO value of -0.05 suggests a bearish momentum in the short term. 
* **Delta_Previous_Relative_Divergence:**  A negative value of -11.1 indicates that the stock has been experiencing a recent downward trend (over the last 20 days). 

**4. Recent Earnings & Outlook:**

CVS has consistently exceeded earnings estimates in the last five quarters. The most recent earnings report, for the quarter ending August 07, 2024, showed EPS of $1.83, exceeding the estimate of $1.73. This demonstrates the company's strong earnings performance. However, the expected growth rate in earnings is currently at 12.6%, indicating that the market might be expecting a slight slowdown in future growth.

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | $1.83 | $1.73 |
| 2024-05-01 | $1.31 | $1.7 |
| 2024-02-07 | $2.12 | $2.01 |
| 2023-11-01 | $2.21 | $2.13 |
| 2023-08-02 | $2.21 | $2.12 |

**5. Overall Analysis:**

CVS is a large healthcare company with a strong track record of exceeding earnings estimates. However, the stock has significantly underperformed the market, indicating a potential lack of investor confidence. Technical indicators show a bearish momentum in the short term. While the recent earnings report was positive, the market may be expecting slower growth in the future.  

**6. Conclusion:**

Based on the analysis, CVS appears to be facing some challenges, despite its strong earnings performance. The stock's lagging performance and bearish technical indicators suggest a potential downside risk in the near term. Investors should carefully monitor the company's future earnings reports and overall market sentiment before considering investing in CVS.
